(Q28366143)

https://api.crossref.org/works/10.1136/BMJ.284.6312.295

14 September 2023

author name string

R. R. Shah

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6277419

14 September 2023

N. S. Oates

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6277419

14 September 2023

J. R. Idle

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6277419

14 September 2023

R. L. Smith

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6277419

14 September 2023

J. D. Lockhart

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6277419

full work available at URL

14 September 2023

language of work or name

English

0 references

publication date

30 January 1982

0 references

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/6277419/pdf/?tool=EBI

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6277419

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/6277419/?tool=EBI

14 September 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6277419

https://europepmc.org/articles/PMC1495859

14 September 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6277419

https://europepmc.org/articles/PMC1495859?pdf=render

14 September 2023

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6277419

https://syndication.highwire.org/content/doi/10.1136/bmj.284.6312.295

14 September 2023

1 reference

Crossref

https://api.crossref.org/works/10.1136/BMJ.284.6312.295

14 September 2023

0 references

284

0 references

page(s)

295-9

0 references

issue

6312

0 references

cites work

Papilloedema and hepatic dysfunction apparently induced by perhexiline maleate (Pexid)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495859

Proximal myopathy after perhexiline maleate treatment

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495859

Pharmacokinetics of perhexiline maleate in anginal patients with and without peripheral neuropathy

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495859

Perhexiline maleate-induced cirrhosis

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495859

Polyneuropathy after perhexiline maleate therapy

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495859

Peripheral-nerve lipid abnormalities in patients on perhexiline maleate

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495859

A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495859

Hepatic disease and drug pharmacokinetics

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495859

Polymorphic hydroxylation of Debrisoquine in man.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495859

Pharmacokinetics of meprobamate in chronic liver diseases and drug addiction

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495859

Letter: Secondary but reversible effects of perhexilin administration

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495859

Proceedings: Clinical evaluation of perhexiline maleate in the treatment of chronic cardiac arrhythmias of patients with coronary heart disease.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495859

Liver damage associated with perhexiline maleate

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495859

Perhexiline maleate in the management of patients with angina pectoris. A long-term assessment.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495859

Papilloedema in patients taking perhexiline maleate.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1495859

Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy

14 July 2018

1 reference

12 December 2020

The break-down of pentobarbital in hepatic diseases

1 reference

12 December 2020

Liver during perhexiline hypoglycaemia

1 reference

12 December 2020

Hypotensive response to debrisoquine and hydroxylation phenotype

1 reference

12 December 2020

Polymorphism of carbon oxidation of drugs and clinical implications

1 reference

12 December 2020

Genetic impairment of phenformin metabolism

1 reference

12 December 2020

Toxicological implications of polymorphic drug metabolism

1 reference

12 December 2020

Influence of DH/DL alleles regulating debrisoquine oxidation on phenytoin hydroxylation

1 reference

12 December 2020

Slow hydroxylation of nortriptyline and concomitant poor debrisoquine hydroxylation: clinical implications

1 reference

12 December 2020

Phenformin-induced lacticacidosis associated with impaired debrisoquine hydroxylation

1 reference

12 December 2020

RATE OF METABOLISM OF TOLBUTAMIDE IN TEST SUBJECTS WITH LIVER DISEASE OR WITH IMPAIRED RENAL FUNCTION

1 reference

12 December 2020

Metabolism of drugs in subjects with Laennec's cirrhosis

1 reference

12 December 2020

Papilloedema in patients taking perhexiline maleate

14

1 reference

Crossref

https://api.crossref.org/works/10.1136/BMJ.284.6312.295

Observations on the metabolic transformation and effects of phenylbutazone in subjects with hepatic disease

14 September 2023

25

1 reference

Crossref

https://api.crossref.org/works/10.1136/BMJ.284.6312.295

14 September 2023

Identifiers

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3401883

OpenCitations bibliographic resource ID

3401883

1 reference